News
EN311 by Eneapharm at ESPGHAN 2025
Apr 10, 2025
We’re proud to be taking part in ESPGHAN 2025, the leading European event dedicated to
Read more
EN311: a true therapeutic breakthrough for EPI
Jan 12, 2025
But first… what is EPI? Exocrine Pancreatic Insufficiency (EPI) is a chronic condition in which
Read more
Eneapharm publishes new results in a leading scientific journal
Nov 8, 2024
We are very happy to announce the release of our latest study in the European
Read more
Eneapharm : Winner of the 2019 i-Lab Competition
Jul 4, 2019
We are proud and honored to have been awarded the prestigious i-Lab Innovation Prize, organized
Read more
Eneapharm signs a collaboration agreement with Crealia, the seed fund of the Occitanie Region, and strengthens its equity capital
Nov 22, 2018
We are proud to announce the signing of a strategic partnership with Crealia, a key
Read more
Eneapharm joins the Nubbo incubation program
Nov 22, 2018
We’re excited to join Nubbo, a leading incubator supporting high-impact technological and societal innovations. This
Read more